Inspire Medical Systems, Inc. (INSP) — Financial statements
Income statement, balance sheet, and cash flow for Inspire Medical Systems, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 912↑13.6% | 803↑28.5% | 625↑53.2% | 408↑74.7% | 233 | |
| Cost of Revenue | 133↑8.3% | 123↑27.3% | 97↑46.1% | 66↑98.7% | 33 | |
| Gross Profit | 779↑14.6% | 680↑28.7% | 528↑54.6% | 342↑70.8% | 200 | |
| Operating Expenses | ||||||
| R&D Expenses | 103↓9.6% | 114↓2.1% | 117↑69.8% | 69↑83.8% | 37 | |
| General & Administrative Expenses | 0.00↓100.0% | 435↑23.6% | 352↑42.7% | 246↑59.1% | 155 | |
| Selling & Marketing Expenses | 0.00↓100.0% | 95↓5.4% | 100↑35.0% | 74↑55.4% | 48 | |
| SG&A Expenses | 625↑17.9% | 530↑17.2% | 452↑40.9% | 321↑58.3% | 203 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 728↑13.1% | 644↑13.2% | 568↑46.0% | 389↑62.2% | 240 | |
| Total Costs & Expenses | 861↑12.3% | 767↑15.3% | 665↑46.0% | 455↑66.7% | 273 | |
| Operating Results | ||||||
| Operating Income | 51↑41.2% | 36↑189.6% | -40↑15.4% | -48↓19.4% | -40 | |
| Depreciation & Amortization | 14↑113.1% | 7↑130.1% | 3↑53.2% | 2↑52.5% | 1 | |
| EBITDA | 65↓0.2% | 65↑481.2% | -17↑58.1% | -41↓5.5% | -39 | |
| EBIT | 51↓12.9% | 58↑393.8% | -20↑53.3% | -43↓6.9% | -40 | |
| Interest & Other Income | ||||||
| Net Interest Income | 17↓25.1% | 23↑13.0% | 21↑509.5% | 3↑268.4% | -2 | |
| Interest Income | 18↓24.6% | 23↑13.1% | 21↑307.1% | 5↑3940.0% | 0.13 | |
| Interest Expense | 0.14↑522.7% | 0.02 | 0.00↓100.0% | 2↓21.2% | 2 | |
| Non-Operating Income | 0.00↑100.0% | -22↓10.0% | -20↓307.2% | -5↓62412.5% | -0.01 | |
| Other Income / Expenses | 15↓34.1% | 22↑9.8% | 20↑512.7% | 3↑256.8% | -2 | |
| Income Before Tax | 66↑12.4% | 58↑393.6% | -20↑55.0% | -44↓5.5% | -42 | |
| Income Tax Expense | -80↓1712.6% | 5↑296.5% | 1↑103.4% | 0.61↑751.4% | 0.07 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 145↑171.8% | 54↑353.0% | -21↑52.9% | -45↓6.8% | -42 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 145↑171.8% | 54↑353.0% | -21↑52.9% | -45↓6.8% | -42 | |
| Bottom-Line Net Income | 145↑171.8% | 54↑353.0% | -21↑52.9% | -45↓6.8% | -42 | |
| EPS (Basic) | 4.95↑175.0% | 1.80↑350.0% | -0.72↑55.0% | -1.60↓3.9% | -1.54 | |
| EPS (Diluted) | 4.89↑179.4% | 1.75↑343.1% | -0.72↑55.0% | -1.60↓3.9% | -1.54 | |
| Weighted Average Shares | 29↓1.3% | 30↑1.6% | 29↑4.4% | 28↑3.0% | 27 | |
| Weighted Average Diluted Shares | 30↓2.6% | 31↑4.2% | 29↑4.4% | 28↑3.0% | 27 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.